Bremelanotide PT-141 Reviews And Warnnings
Bremelanotide ( PT – 141), began development in 2004 and is still undergoing trials. Bremelanotide is a peptide melanocortin receptor antagonist which is under current development by Palatin Technologies as the treatment for sexual dysfunction. It is made from the peptide Melanotan II, which underwent testing as a sunless tanning agent. In initial testing, it…
